Sequenom’s ‘incorporeal’ prenatal genetic test unpatentable, Ariosa tells Full Court

Adrian Ryan 2020-06-29 9:12 pm By Miklos Bolza | Sydney

Please login to bookmark

Ariosa Diagnostics is fighting to revoke a patent for noninvasive prenatal test owned by Sequenom, arguing it merely describes how to extract “incorporeal” genetic information that is naturally found within the DNA of an unborn foetus.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au